Protein-ligand interaction energy analysis between anti-trypanosome drug candidate and target protein using fragment molecular orbital

  • Ryunosuke Yoshino
    Global Scientific Information and Computing Center, Tokyo Institute of Technology
  • Nobuaki Yasuo
    Department of Computer Science, Tokyo Institute of Technology
  • Yohsuke Hagiwara
    Chemistry Research Labs, Drug Discovery Research, Astellas Pharma Inc
  • Kazuki Ohno
    Chemistry Research Labs, Drug Discovery Research, Astellas Pharma Inc
  • Masaya Orita
    Global Scientific Information and Computing Center, Tokyo Institute of Technology | Chemistry Research Labs, Drug Discovery Research, Astellas Pharma Inc
  • Masayuki Inoue
    Graduate School of Pharmaceutical Sciences, The University of Tokyo
  • Shigeharu Harada
    Graduate School of Science and Technology, Kyoto Institute of Technology
  • Teruki Honma
    Graduate School of Medicine, The University of Tokyo
  • Daniel KenInaoka
    Graduate School of Medicine, The University of Tokyo
  • Kiyoshi Kita
    Graduate School of Medicine, The University of Tokyo
  • Masakazu Sekijima
    Global Scientific Information and Computing Center, Tokyo Institute of Technology | Department of Computer Science, Tokyo Institute of Technology

Bibliographic Information

Other Title
  • FMO法を用いた抗トリパノソーマ候補薬と標的蛋白質間の相互作用解析

Search this article

Abstract

Chagas' disease caused by Trypanosoma cruzi is known as neglected tropical diseases (NTD's). To develop effective anti-Trypanosome drug, we remarked dihydroorotate dehydrogenase which assumed synthesis of orotic acid and studied inhibitor of the enzyme. Although X-ray structure of target protein with inhibitor is clarified, important protein-ligand interaction is not determined for elucidation of inhibition mechanism. Then, in this research, we analyzed interaction energy between target proteins and inhibitors using fragment molecular orbital method. As a result, it was revealed that hydrogen bonding with Lys and Asn was important. It is expected that these results are useful for anti-Trypanosome drug design.

Journal

Details 詳細情報について

  • CRID
    1573668927652772992
  • NII Article ID
    110009634027
  • NII Book ID
    AA12055912
  • ISSN
    09196072
  • Text Lang
    ja
  • Data Source
    • CiNii Articles

Report a problem

Back to top